|
Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder Clinical research trials and Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder. Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder clinical trial. Test subjects typically receive the most effective healthcare possible for their Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder  Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder
Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder
For Condition: Bipolar Disorder
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: The purpose of this study is to learn if aripiprazole is effective for the treatment of patients with acute symptoms of Bipolar disorder.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Patients with acute symptoms of Bipolar Disorder
Total Enrollment:
Location and Contact Information:
Local Institution
Indianapolis, Indiana,
United States
Local Institution
Falls Church, Virginia,
United States
Local Institution
Newton Center, Massachusetts,
United States
Local Institution
Austin, Texas,
United States
Local Institution
Cincinnati, Ohio,
United States
Local Institution
San Diego, California,
United States
Local Institution
Miami, Florida,
United States
Local Institution
New Baltimore, Michigan,
United States
Local Institution
San Diego, California,
United States
Local Institution
Medina, Ohio,
United States
Local Institution
Washington D.C., District of Columbia,
United States
Local Institution
Tuscallosa, Alabama,
United States
Local Institution
Riverside, California,
United States
Local Institution
Stanford, California,
United States
Local Institution
Houston, Texas,
United States
Local Institution
Chicago, Illinois,
United States
Local Institution
Louisville, Kentucky,
United States
Local Institution
Honolulu, Hawaii,
United States
Local Institution
Lawrence, New York,
United States
Local Institution
Philadelphia, Pennsylvania,
United States
Local Institution
Beachwood, California,
United States
Local Institution
San Clemente, California,
United States
Local Institution
Little Rock, Arizona,
United States
Local Institution
Houston, Texas,
United States
Local Institution
Winter Park, Florida,
United States
Local Institution
Butner, North Carolina,
United States
Local Institution
Belmont, Massachusetts,
United States
Local Institution
Bellevue, Washington,
United States
Local Institution
Chula Vista, California,
United States
Local Institution
Cincinnati, Ohio,
United States
Additional Information:
Study ID Numbers: CN138-074;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036101
Other Bipolar Disorder Studies:
1. Study of the Psychological Development of Children of Parents with and without Affective Disorders
2. Seroquel plus Mood Stabilizer Compared to Placebo plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
3. Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
4. Bipolar Study
5. Combination Therapy for the Treatment of Bipolar Disorders
Related Studies:
Other Bipolar Disorder Clinical Trials
Other North Carolina Clinical Trials
Other Butner Clinical Trials
Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder
|
|
|
|
|
|
|
|
